TBA Law Blog

Posted by: Suzanne Craig Robertson on Mar 27, 2012

The U.S. Supreme Court on Monday threw out a lower court ruling allowing human genes to be patented, a topic of enormous interest to cancer researchers, patients and drug makers. The court overturned patents belonging to Myriad Genetics Inc. of Salt Lake City on two genes linked to increased risk of breast and ovarian cancer. The Daily News has the AP story